The groundbreaking therapy of this peptide represents a major advance in the care of the condition. Different to existing medications, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide625643.newbigblog.com/48994209/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment